2025年更新的HIV-1药物耐药性突变
Annemarie M Wensing1, Vincent Calvez2, Francesca Ceccherini-Silberstein3
1University Medical Center Utrecht, The Netherlands and Ezintsha, University of the Witwatersrand, Johannesburg, South Africa.
Topics in antiviral medicine
|June 5, 2025
概括
新的HIV-1耐药突变随着抗逆转录病毒药物暴露而出现,影响治疗的有效性. 这份最新的清单有助于临床医生为艾滋病毒治疗方案做出明智的决定.
科学领域:
- 传染性疾病 传染性疾病
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗逆转录病毒药物对于管理人类免疫缺陷病毒1型 (HIV-1) 感染至关重要.
- 在治疗期间,HIV-1的突变可能会出现,导致耐药性和治疗效率降低.
- 国际抗病毒学会-美国 (IAS-USA) 提供药物耐药性突变的最新列表,以指导临床实践.
研究的目的:
- 提出2025年更新的HIV-1药物耐药性突变清单.
- 识别导致抗逆转录病毒药物病毒学反应减少的突变.
- 帮助临床医生做出明智的HIV治疗决策.
主要方法:
- 自2022年11月更新以来新获得的数据的汇编.
- 鉴定符合导致病毒反应减少的特定标准的突变.
- 包括与目前可用的抗逆转录病毒药物耐药性相关的突变.
主要成果:
- 2025年IAS-USA清单包括有关HIV-1耐药性突变的最新信息.
- 确定了影响当前和未来艾滋病毒治疗有效性的关键突变.
- 该清单是理解治疗失败和优化药物选择的关键资源.
结论:
- 更新的IAS-USA清单对于治疗艾滋病毒的从业人员来说至关重要.
- 了解这些突变有助于选择适当的抗逆转录病毒疗法.
- 该资源支持临床决策,以改善患者的治疗结果,避免治疗失败.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


